|
시장보고서
상품코드
1529407
세계의 시퀀서 시장(2023-2028년)Worldwide Sequencer Market, 2023-2028 |
||||||
이 보고서는 세계 시퀀서 시장을 조사했으며, 시장 동향과 함께 2023년까지의 과거 데이터와 2028년까지의 예측 데이터를 제공합니다. 또한, 시장 진출기업 프로파일을 포함한 종합적인 고찰을 제공합니다.
목차
제2장 시장 발전과 동향
- 시퀸서 시장은 안정되어 있지만 변화의 조짐 있어
- 주요 벤더의 시퀸서 시스템과 성능
- 이득 정보
- 동향
- 임상 응용
- 액체 생검 및 순환 핵산
- 규제와 표준화 대처
- 중앙화를 통한 접근성 향상
- 경쟁 심화 가능성
- NGS 기술 진보
- 롱 리드 시퀀싱
- 단세포 시퀀싱
- 후성 유전 시퀀싱
- 하이스루풋(High throughput) 시퀀싱
- 실시간 시퀀싱
- 포터블 시퀀싱 디바이스
- 직접 RNA 시퀀싱
- 공간 전사체학
- 메타게노믹스 및 마이크로바이옴
- 멀티 오믹스 통합
제3장 시장 분석
- 개요
- 시퀸서 시장, 제품 유형별
- 시퀸서 시장, 국가/지역별
- 시장 점유율
제4장 기업 개요
- 10X Genomics
- Agilent Technologies
- BGI(Beijing Genomics Inst.)
- 산전 검사
- 테스트 서비스
- 전유전체 시퀀싱(WGS)
- NGS 시퀀싱
- 협업
- Berry Genomics
- CareDx
- CareDx가 제공하는 검사 서비스
- CareDx가 제공하는 제품
- 엘리먼트 바이오사이언스
- 정확한 과학
- 최근 매출과 동향
- Illumina
- 진단
- 기타 협업과 발표
- 중국
- New England Biolabs
- Oxford Nanopore Technologies
- Pacific Biosciences(PacBio)
- 배경과 기타 소식
- Qiagen
- 액체생검
- Revvity
- 시퀀싱/유전체학
- 액체생검
- 출산전 비즈니스
- 실험실 서비스
- Singular Genomic
- Takara Bio
- Tecan
- Thermo Fisher Scientific
- 차세대 시퀀싱
- 이식 의료
- 마이크로바이옴
- 기타 협업과 인수
- 유전자 편집과 세포치료
- 울티마 유전체학
Kalorama Information's new comprehensive report, "Worldwide Sequencer Market, 2023-2028", provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.
The report offers historical data for 2023 and forecast data through 2028, focusing on the market for sequencing systems and products. This encompasses systems, consumables, software, and system servicing, related to the DNA and RNA sequencing process.
Kalorama Information has been closely monitoring the market for next-generation sequencing (NGS) systems since their inception. The report discusses the rapid growth and transformation of the sequencing market over the past decade, driven by technological advancements, expanding applications, and decreasing costs. It provides comprehensive insights into market share, revenue growth, competitive dynamics, and company profiles.
NGS technology has become a staple in the life sciences, offering significant improvements in performance and output while reducing costs in line with Moore's Law. Some systems now enable genome sequencing at costs as low as $100-$200. The technology is widely used for applications including:
- Whole genome sequencing
- Targeted/amplicon resequencing
- Exome sequencing
- SNP analysis
- RNA sequencing
- Gene expression profiling
- Transcriptomics
- Small RNA/miRNA analysis
- ChIP-seq
- Methylation analysis
- Metagenomics
"Worldwide Sequencer Market, 2023-2028" provides a comprehensive overview of these applications and examines the trends and challenges shaping the future of the sequencing market.
Kalorama Information's new comprehensive report, Worldwide Sequencer Market, 2023-2028 , provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.
The report offers historical data for 2023 and forecast data through 2028, focusing on the market for sequencing systems and products. This encompasses systems, consumables, software, and system servicing, related to the DNA and RNA sequencing process."
Kalorama Information has been closely monitoring the market for next-generation sequencing (NGS) systems since their inception. The report discusses the rapid growth and transformation of the sequencing market over the past decade, driven by technological advancements, expanding applications, and decreasing costs. It provides comprehensive insights into market share, revenue growth, competitive dynamics, and company profiles.
NGS technology has become a staple in the life sciences, offering significant improvements in performance and output while reducing costs in line with Moore's Law. Some systems now enable genome sequencing at costs as low as $100-$200. The technology is widely used for applications including:
- Whole genome sequencing
- Targeted/amplicon resequencing
- Exome sequencing
- SNP analysis
- RNA sequencing
- Gene expression profiling
- Transcriptomics
- Small RNA/miRNA analysis
- ChIP-seq
- Methylation analysis
- Metagenomics
Worldwide Sequencer Market, 2023-2028 provides a comprehensive overview of these applications and examines the trends and challenges shaping the future of the sequencing market.
Table of Contents
Chapter 1: Executive Summary
- Table 1-1: World Sequencer Market, 2023-2028 (in $ millions)
- Figure 1-1: World Sequencer Market, 2023-2028 (in $ millions)
- Figure 1-2: Annual Growth in World Sequencer Market, 2023-2028 (%)
- Table 1-2: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
- Figure 1-3: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
- Figure 1-4: World Sequencer Market Compound Annual Growth Rate (CAGR), by Product Segment, 2023-2028 (%)
- Table 1-3: World Sequencer Market, Shares by Product Segment, 2023-2028 (%)
- Figure 1-5: World Sequencer Market, Shares by Product Segment, 2023 (%)
- Figure 1-6: Cost of Sequencing a Human Genome, 2001-2023 (in $ millions)
- Current Trends
- Scope and Methodology
- Report Structure
Chapter 2: Market Development and Trends
- Sequencer Market Stable But Poised for Changes
- Major Vendors' Sequencer Systems and Performance
- Table 2-1: Selected Short-Read Sequencer Systems' Performance, 2024
- Table 2-2: Selected Long-Read Sequencer Systems' Performance, 2024
- Deals
- Table 2-3: Deals in Sequencer Market, January 2020-July 2024
- Trends
- Clinical Applications
- Liquid Biopsy, Circulating Nucleic Acids
- Regulatory and Standardization Efforts
- Increased Access Through Decentralization
- Potential for Increasing Competition
- Advancements in NGS Technology
- Long-Read Sequencing
- Single Cell Sequencing
- Epigenetic Sequencing
- High-Throughput Sequencing
- Real-time Sequencing
- Portable Sequencing Devices
- Direct RNA Sequencing
- Spatial Transcriptomics
- Metagenomics, Microbiome
- Multi-Omics Integration
Chapter 3: Market Analysis
- Overview
- Table 3-1: World Sequencer Market, 2023-2028 (in $ millions)
- Figure 3-1: World Sequencer Market, 2023-2028 (in $ millions)
- Figure 3-2: Illumina Revenue Annual Growth Rate, 2010-2023 (%)
- Figure 3-3: Illumina Revenue Growth Rate 4-Year Moving Average, 2014-2023 (in $ millions)
- Sequencer Market by Product Types
- Table 3-2: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
- Table 3-3: World Sequencer Market, Shares by Product Segment, 2023-2028 (%)
- Figure 3-4: World Sequencer Market, Share by Product Segment, 2023 (%)
- Figure 3-5: World Sequencer Market, Share by Product Segment, 2028 (%)
- Sequencer Market by Country and Region
- Table 3-4: Geographic Breakout of the World Sequencer Market, by Country/Region (APAC, Europe, North America, Rest of World), 2023 (in $ millions)
- Figure 3-6: Geographic Breakout of the World Sequencer Market, by Country/Region (APAC, Europe, North America, Rest of World), 2023 (in $ millions)
- Figure 3-7: Geographic Breakout of the World Sequencer Market, Share by Country/Region (APAC, Europe, North America, Rest of World), 2023 (%)
- Market Shares
- Figure 3-8: World Sequencer Market, by Estimated Market Shares, by Company (Agilent, Illumina, MGI Tech, MilliporeSigma, Oxford Nanopore, Pacific Biosciences, Qiagen, Roche, Thermo Fisher, Other), 2023 (%)
Chapter 4: Company Profiles
- 10X Genomics
- Agilent Technologies
- BGI (Beijing Genomics Inst.)
- Prenatal Testing
- Test Services
- Whole Genome Sequencing (WGS)
- NGS Sequencing
- Collaborations
- Berry Genomics
- CareDx
- Figure 4-1: CareDx Revenue, 2017-Q1 2024 (in $ millions)
- Testing Services Offered by CareDx
- AlloMap Tests
- AlloSure Tests
- Products Offered by CareDx
- Element Biosciences
- Exact Sciences
- Recent Revenues and Developments
- Illumina
- Table 4-1: Illumina's Revenue History, 2015-2023 (in $ millions)
- Figure 4-2: Illumina's Revenue History, 2017-Q1 2024 (in $ millions)
- Diagnostics
- Other Collaborations and Announcements
- China
- New England Biolabs
- Oxford Nanopore Technologies
- Pacific Biosciences (PacBio)
- Background and Other Announcements
- Qiagen
- Liquid Biopsy
- Revvity
- Sequencing/Genomics
- Liquid Biopsy
- Prenatal Business
- Lab Services
- Singular Genomic
- Takara Bio
- Tecan
- Thermo Fisher Scientific
- Next-Generation Sequencing
- Transplant Medicine
- Microbiome
- Other Collaborations and Acquisitions
- Gene Editing and Cell Therapy
- Ultima Genomics
